
inglés
Tecnología y ciencia
Oferta limitada
Después 4,99 € / mesCancela cuando quieras.
Acerca de A pinch of salt - A podcast by ERA
Welcome to "A Pinch of Salt- A podcast by ERA". Each month, we'll release three episodes with nephrologists and other physicians who have other interests outwith medicine. Hosts: Andrej Skoberne and George KosmadakisAn initiative by ECC – Electronic Communication Committee
#66 Patient-reported outcomes in clinical practice, with Paul Cockwell
In this episode of A pinch of salt we’ll be talking to Paul Cockwell about patient-reported outcomes in clinical practice. You may or may not be aware of these issues and their importance but one might argue, and we certainly would, that every doctor should be mindful of what their patients consider to be an important outcome and whether they are achieving it or not. Paul is a champion of this field, and he provided some very useful pointers on how a beginner in this field might get to know it and start working on these issues in his or her clinical practice. The SONG initiative will be mentioned, as well as a useful systematic review on symptom burden and health-related quality of life in CKD, and a shout out to a recent important paper published in CKJ (doi: 10.1093/ckj/sfaf112 [https://doi.org/10.1093/ckj/sfaf112]). Learn about the art of trying to meet the patients’ needs in this knowledge-packed episode.
#65 About the GFR formulas – How to measure renal function in 2026? with Pierre Delanaye
In this episode of A pinch of salt, we welcome Pierre Delanaye for a forward-looking discussion on how we should assess kidney function in 2026. Together, we explore the strengths and limits of today’s GFR equations (MDRD, CKD-EPI, cystatin C-based approaches), the promise of emerging biomarkers and AI-driven tools, and the crucial question of fairness and accuracy across diverse populations.
#64 Evolution of Treatment Paradigms in ANCA Vasculitis, with David Jayne
Join A pinch of salt, as we sit down with David Jayne to trace the rapid transformation of ANCA-associated vasculitis care. From the historic cyclophosphamide–glucocorticoid backbone to biologics like rituximab and newer targeted strategies such as complement inhibition (including avacopan), this episode unpacks how clinicians can balance efficacy, safety, and quality of life—while looking ahead to what may define the next decade of treatment.
#63 Treatment of obesity in patients with CKD, with Allon N. Friedman
In this episode of A pinch of salt, Allon N. Friedman will talk about possibly the hottest topic in medicine at this moment – the treatment of obesity, with a particular focus on treating the CKD population. Obesity is finally being recognized as a disease and not merely an unfortunate, somewhat shameful consequence of personalities with weak minds and lack of willpower. But how do we treat it? Does changing lifestyle have any impact, should everybody start taking weight lowering medications, what about surgery? As always, we’ll be trying to provide you with some helpful clinical information that might help you and your patients in regular clinical practice.
#62 Chronic kidney disease of unknown etiology, with Shuchi Anand
In this episode of A pinch of salt, Shuchi Anand will talk about chronic kidney disease of unknown etiology, the mysterious kidney disease that is devastating some agricultural communities in hot environments. Dr Anand will talk about what might be causing this disease, does a kidney biopsy help, is it mandatory, and how to treat these patients both on the individual level and on the population level to tackle this disease locally and globally. Learn more about this true medical mystery, with stories from the literature and stories from the field.
Elige tu suscripción
Oferta limitada
Premium
20 horas de audiolibros
Podcasts solo en Podimo
Podcast gratuitos
Cancela cuando quieras
2 meses por 1 €
Después 4,99 € / mes
Premium Plus
100 horas de audiolibros
Podcasts solo en Podimo
Podcast gratuitos
Cancela cuando quieras
Disfruta 30 días gratis
Después 9,99 € / mes
2 meses por 1 €. Después 4,99 € / mes. Cancela cuando quieras.